List of insiders holdings for CASI Pharmaceuticals, Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | He Wei-Wu Director 10% Owner | 2026-05-18 16:30:15 | 23,985,535 0 | 23,985,535 | Form 13D |
| 2 | Huang James Director | 2026-03-18 16:30:37 | 121,571 4,529,956 | 4,651,527 | Form 3 |
| 3 | Huang Hai Global Chief Commercial Ofcr | 2026-04-07 16:30:15 | 280,000 0 | 280,000 | Form 3 |
| 4 | Wang Chunhua Chief Operating Officer | 2026-04-03 16:30:39 | 235,000 0 | 235,000 | Form 3 |
| 5 | Wu Alex Director | 2026-03-25 07:36:36 | 139,310 0 | 139,310 | Form 3 |
| 6 | Zukiwski Alexander A Global Chief Medical Officer | 2026-04-03 16:30:12 | 116,333 0 | 116,333 | Form 3 |
| 7 | Gao Wei R General Counsel | 2026-04-16 16:30:13 | 84,000 0 | 84,000 | Form 3 |
| 8 | Qian Kun Global Controller | 2026-04-13 16:30:12 | 75,000 0 | 75,000 | Form 3 |
| 9 | Folinsbee Thomas Director | 2026-04-23 06:00:38 | 53,693 0 | 53,693 | Form 3 |
| 10 | Zeng Xuebo Director | 2026-04-20 21:33:08 | 33,693 0 | 33,693 | Form 3 |
| 11 | Krebs-Pohl Barbara Helene Hannelore Director | 2026-03-27 08:19:59 | 20,000 0 | 20,000 | Form 3 |